The Net Margin of Huakang Biomedical Holdings Co Ltd (8622.HK) is -16.40%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -16.40% |
| 2023-12-31 | -23.48% |
| 2022-12-31 | -12.14% |
| 2021-12-31 | -16.15% |
| 2020-12-31 | -52.93% |
| 2019-12-31 | -1.11% |
| 2018-12-31 | -1.60% |
| 2017-12-31 | -7.35% |
| 2016-12-31 | 33.16% |
| 2015-12-31 | 40.78% |